MedTrace Logo

Safety and Efficacy Evaluation of Mouth Wash(Glister Mouth Wash): Pilot Study

NCT05644236 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 86

Last updated 2022-12-09

No results posted yet for this study

Summary

The goal of this clinical trial is to examine the efficacy of mouthwash containing 0.045% cetylpyridinium chloride (CPC) on oral health-related parameters\] in \[healthy conditions\]. The main question\[s\] it aims to answer are:

* \[ Trial 1: effect of immediate-use mouthwash containing CPC vs. non-CPC\]
* \[Trial 2: effect of concentrated-use mouthwash containing CPC vs. non-CPC\] Participants will be treated by mouth wash 3 times a day for 4-weeks If there is a comparison group: Researchers will compare CPC containing mouthwash group and sham mouthwash groups treated with non CPC-containing mouthwash to see the effect of CPC on plaque index, mouth smell, gingival index and tongue coating index.

Conditions

  • Oral Hygiene
  • Gingival Index
  • Cetylpyridinium Chloride

Interventions

OTHER

mouthwash

After obtaining baseline information and randomizing the participants into two groups, dental scaling was performed, followed by clinical treatment. The participants were instructed to gargle twice daily for 7 days. All the participants were instructed not to eat or drink anything for at least 4 hours before the experiment. Oral hygiene, such as gargling and tooth brushing, was prohibited for 8 hrs before the visit.

Sponsors & Collaborators

  • Wonju Severance Christian Hospital

    lead OTHER

Principal Investigators

  • Kyu-Jae Lee, Ph.D. · Wonju College of Medicine, Yonsei University, Republic of Korea

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-09-27
Primary Completion
2021-11-30
Completion
2021-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05644236 on ClinicalTrials.gov